This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leow, C. C. Articles by Gao, W.-Q. Search for Related Content PubMed PubMed Citation Articles by Leow, C. C. Articles by Gao, W.-Q.

Hath1, Down-Regulated in Colon Adenocarcinomas, Inhibits Proliferation and Tumorigenesis of Colon Cancer Cells

Department of Molecular Oncology, Genentech, Inc., South San Francisco, California

A striking feature of colon tumors is the significant reduction of goblet cells. Although targeted deletion of Math1 in mice leads to a loss of intestinal secretory cells, including goblet cells, the role of Hath1 in colon tumorigenesis remains unknown. Here we report that Hath1, the human ortholog of Math1, was dramatically down-regulated in colon tumor samples and colon cancer cell lines. Overexpression of Hath1 in HT29, an aggressive colon cancer cell line, resulted in a significant inhibition on cell proliferation, anchorage-independent growth in soft agar and, more importantly, growth of human colon cancer cell xenografts in athymic nude mice. Such inhibition was accompanied by altered expression of a goblet cell differentiation marker, MUC2, and cell cycle regulators cyclin D1 and p27^kip1. Hath1 expression also was up-regulated on inhibition of the Wnt pathway, which has been well implicated in colon tumorigenesis. Hence, this study suggests that Hath1 may be a novel factor downstream of the Wnt pathway capable of suppressing anchorage-independent growth of colon cancer cell lines. More importantly, this study is the first to establish a link between down-regulation of Hath1 expression and colon tumorigenesis.

This article has been cited by other articles:

				Z. Wang, Y. Hao, and A. W. Lowe The Adenocarcinoma-Associated Antigen, AGR2, Promotes Tumor Growth, Cell Migration, and Cellular Transformation Cancer Res., January 15, 2008; 68(2): 492 - 497. [Abstract] [Full Text] [PDF]

				E. T. Park, H. K. Oh, J. R. Gum Jr., S. C. Crawley, S. Kakar, J. Engel, C. C. Leow, W.-Q. Gao, and Y. S. Kim HATH1 Expression in Mucinous Cancers of the Colorectum and Related Lesions. Clin. Cancer Res., September 15, 2006; 12(18): 5403 - 5410. [Abstract] [Full Text] [PDF]

				S.-L. Tzeng, Y.-W. Cheng, C.-H. Li, Y.-S. Lin, H.-C. Hsu, and J.-J. Kang Physiological and Functional Interactions between Tcf4 and Daxx in Colon Cancer Cells J. Biol. Chem., June 2, 2006; 281(22): 15405 - 15411. [Abstract] [Full Text] [PDF]

				C. C. LEOW, P. POLAKIS, and W.-Q. GAO A Role for Hath1, a bHLH Transcription Factor, in Colon Adenocarcinoma Ann. N.Y. Acad. Sci., November 1, 2005; 1059(1): 174 - 183. [Abstract] [Full Text] [PDF]

				Y. Ishikawa Wnt Signaling and Orthopedic Diseases Am. J. Pathol., July 1, 2005; 167(1): 1 - 3. [Full Text] [PDF]